A Novel, Low-Cost, Handheld 3D Imaging System for Improved Screening for Cervical Neoplasia in Resource-Limited Settings

NAActive, not recruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 16, 2025

Primary Completion Date

May 16, 2025

Study Completion Date

July 16, 2025

Conditions
Cervical Intraepithelial Neoplasia
Interventions
DEVICE

CervImage device

"CervImage™, developed by Pensievision, Inc., is an accessible, simple, cost-effective, early detection imaging technology for preventing cervical cancer deaths caused by a lack of screening.~The novel device is a simple-to-operate, point-of-care, all-focus, 3D-imaging device, with clinical relevance to early-stage detection and prevention of cervical cancers. CervImage's proprietary 3D-rendering software, incorporating strategies previously used for high resolution imaging with NASA telescopes, can quantify tissue color, volume and shape. Virtual navigation tools and all-focus imaging enable straightforward use by minimally trained personnel; expert personnel can also benefit from shorter setup times.~The research procedure and evaluation will be incorporated into the scheduled annual pap smear exam or colposcopic gynecologic exam that involves using a vaginal speculum."

Trial Locations (1)

24013

Carilion Clinic, Roanoke

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Pensievision, Inc

UNKNOWN

lead

Carilion Clinic

OTHER

NCT06810427 - A Novel, Low-Cost, Handheld 3D Imaging System for Improved Screening for Cervical Neoplasia in Resource-Limited Settings | Biotech Hunter | Biotech Hunter